Something to Watch
Filed in archive Investing by Alex Akesson on March 30, 2007
Interesting article here; Osiris Rises on Heart-Treatment News.
Investors bid up Osiris Therapeutics stock by 13.6% to $20.33 per share in early trading on the Nasdaq on March 26 after the company's stem cell treatment produced positive results in a clinical trial.
When Osiris Therapeutics (OSIR) announced encouraging results from its effort to help the hundreds of thousands who die each year because their scarred hearts can no longer pump blood efficiently, investors bid up the Baltimore stem cell therapeutic company's stock on March 26.
Also up is Alexza Pharmaceuticals (ALXA) who announced encouraging results on Mar. 26 from two studies intended to develop new treatments for migraine victims and schizophrenic patients with acute agitation
.
Investors bid up Alexza's stock by more than 52% to $15.21 per share on the Nasdaq March 26. Story here.
Good article in the Kingsland report.
Investors bid up Osiris Therapeutics stock by 13.6% to $20.33 per share in early trading on the Nasdaq on March 26 after the company's stem cell treatment produced positive results in a clinical trial.
Also up is Alexza Pharmaceuticals (ALXA) who announced encouraging results on Mar. 26 from two studies intended to develop new treatments for migraine victims and schizophrenic patients with acute agitation
.Investors bid up Alexza's stock by more than 52% to $15.21 per share on the Nasdaq March 26. Story here.
Good article in the Kingsland report.
Permalink: Something to Watch
Tags:
hedge+fund hedge funds fund home hedge+funds something+watch
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/60545
